| Inhibition of respiratory growth and survival in yeast by dopamine and counteraction with ascorbate or glutathione. | |
| | |
MedLine Citation:
|
PMID: 20145104 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Dopamine is a key monamine neurotransmitter, yet it can also exhibit toxicity to neuronal cells. There are suggestions that dopamine may be neurotoxic due to its propensity to induce the formation of reactive oxygen species, which may in turn adversely affect mitochondrial function and cell viability. In this study, the effects of dopamine or a dopamine reaction product on yeast growth and survival have been explored. Yeast is ideal for such a study because, unlike mammalian cells, yeast cells can be grown even when respiratory function is totally absent. Indeed, dopamine was found to be inhibitory to yeast growth in media where respiratory function was required and cytotoxic to yeast cells suspended in water. The inhibitory effects of dopamine were reduced greatly by the antioxidants ascorbate and glutathione, suggesting the involvement of reactive oxygen species in dopamine-mediated toxicity. It would appear that yeast may offer a convenient model to perform screens for further compounds that may provide protection against dopamine-mediated growth inhibition and toxicity. |
| | |
Authors:
|
Ian G Macreadie; Nick Bartone; Lindsay Sparrow |
Related Documents
:
|
16362334 - 5-(4-chlorophenyl)-1-(4-methoxyphenyl)-3-trifluoromethylpyrazole acts in a reactive oxy... 18587814 - Oxygen transfer properties of a bioreactor for use within a nuclear magnetic resonance ... 2036004 - Cometabolism of 3,4-dichlorobenzoate by acinetobacter sp. strain 4-cb1. 9576744 - Protection from reoxygenation injury by inhibition of rac1. 7021184 - Isolated kupffer cells, endothelial cells and hepatocytes as investigative tools for li... 27304 - Quantitative characteristics of the feyrter cells and neuroepithelial bodies of the fet... |
Publication Detail:
|
Type: Journal Article Date: 2010-02-09 |
Journal Detail:
|
Title: Journal of biomolecular screening Volume: 15 ISSN: 1552-454X ISO Abbreviation: J Biomol Screen Publication Date: 2010 Mar |
Date Detail:
|
Created Date: 2010-03-09 Completed Date: 2010-06-28 Revised Date: 2011-05-23 |
Medline Journal Info:
|
Nlm Unique ID: 9612112 Medline TA: J Biomol Screen Country: United States |
Other Details:
|
Languages: eng Pagination: 297-301 Citation Subset: IM |
Affiliation:
|
CSIRO Molecular and Health Technologies and P-Health Flagship, Parkville, Victoria, Australia. imacreadie@siennadiagnostics.com.au |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Aerobiosis
/
drug effects Ascorbic Acid / pharmacology* Candida / cytology, drug effects, growth & development Culture Media / pharmacology Dopamine / toxicity* Glutathione / pharmacology* Microbial Viability / drug effects* Saccharomyces cerevisiae / cytology, drug effects, growth & development Solutions Yeasts / cytology*, drug effects, growth & development* |
| Chemical | |
Reg. No./Substance:
|
0/Culture Media; 0/Solutions; 50-81-7/Ascorbic Acid; 70-18-8/Glutathione |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: BacMam-enabled LanthaScreen cellular assays for PI3K/Akt pathway compound profiling in disease-relev...
Next Document: Natural variation for seed dormancy in Arabidopsis is regulated by additive genetic and molecular pa...